CYP1B1 Gene and Prostate Cancer Risk
Author Information
Author(s): Chang B L, Zheng S L, Isaacs S D, Turner A, Hawkins G A, Wiley K E, Bleecker E R, Walsh P C, Meyers D A, Isaacs W B, Xu J
Primary Institution: Wake Forest University School of Medicine
Hypothesis
Polymorphisms in CYP1B1 may affect the risk for prostate cancer.
Conclusion
The study found an association between certain CYP1B1 gene polymorphisms and an increased risk of sporadic prostate cancer.
Supporting Evidence
- The study included 159 hereditary prostate cancer probands and 245 sporadic prostate cancer cases.
- Significant differences in allele frequencies were observed between sporadic cases and controls for several SNPs.
- Haplotype analysis revealed larger differences between sporadic cases and unaffected controls.
Takeaway
This study looked at how changes in a specific gene might make people more likely to get prostate cancer, and they found some links.
Methodology
The study compared the frequencies of CYP1B1 SNPs among hereditary prostate cancer probands, sporadic prostate cancer cases, and unaffected controls.
Potential Biases
Potential for population stratification affecting genotype frequencies.
Limitations
The results may be influenced by population stratification and were not adjusted for multiple comparisons.
Participant Demographics
Majority were Caucasian (over 90%); included 159 hereditary prostate cancer families, 245 sporadic cases, and 222 controls.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website